[ad_1]
Covishield Corona vaccine is being produced in the country by Serum Institute of India, Pune. Covishield is one of two vaccines approved by India for emergency use on corona. The Serum Institute is the world’s largest vaccine manufacturer. The vaccine is being supplied by India to many countries during the Corona crisis. On the other hand, there was a shortage of vaccines in many states in India. Other states, including Maharashtra, Punjab and Rajasthan, had run out of vaccines. The government took immediate steps to address the shortage. The Center has clarified that there is no shortage of vaccines in the country.
PM care fund to have its own oxygen plant in 100 new hospitals, big decision of the Center
Production of Novavax vaccine on Corona stopped
The raw material required for vaccine production is insufficient. The United States has imposed restrictions on the export of raw materials due to the enactment of the Defense Act. This has already been stated by Adar Punawala. “Restrictions on raw materials are the same as restrictions on vaccines,” Punawala said. Serum Institute Novavax is developing the vaccine. But due to the problem of raw materials, the production of vaccine has to be stopped.
Medical Oxygen: Lack of oxygen in the country, decision of the Center to import from abroad
Raw materials were imported from America
We import large quantities of raw materials from the United States. It has a long list. This includes filters, bags, some solutions. In such a situation it will take time to find a new supplier. The company is looking for new suppliers. After 6 months, it will not depend on America. But right now, the company is in dire need of raw materials, ”Adar Punawala said in an interview with Business Standard.
[ad_2]
Source link